Contact us

Investors

Shield Therapeutics is well positioned to become a fast growing, independent, international specialty pharmaceutical company.

Corporate Documents

Preliminary Results for the Year Ended 31 December 2018

Type:

PDF

Date:

03 Apr 2019

UK Corporate Governance Code disclosures

Type:

PDF

Date:

28 Sep 2018

Shield Therapeutics Interim Results 2018

Type:

PDF

Date:

05 Jun 2018

Shield Therapeutics plc - Annual Report and Accounts for year ended 2017

Type:

PDF

Date:

05 Jun 2018

Shield Therapeutics plc - AGM 2018 Shareholder Letter

Type:

PDF

Date:

05 Jun 2018

Shield Therapeutics plc - Notice of AGM 2018

Type:

PDF

Date:

05 Jun 2018

Shield Therapeutics Preliminary Results 2017

Type:

PDF

Date:

11 Apr 2018

Shield Therapeutics Interim Results 2017

Type:

PDF

Date:

30 Jun 2017

Notice of Annual General Meeting 2017

Type:

PDF

Size:

189KB

Date:

28 Apr 2017

Annual Report 2016

Type:

PDF

Size:

700KB

Date:

28 Apr 2017

2016 Preliminary Results

Type:

PDF

Size:

320KB

Date:

04 Apr 2017

2016 Interim Report

Type:

PDF

Size:

817KB

Date:

20 Sep 2016

2016 Interims Press Release

Type:

PDF

Size:

833KB

Date:

20 Sep 2016

Notice of Annual General Meeting 2016

Type:

PDF

Size:

2,000KB

Date:

15 Jul 2016

Annual Report 2015

Type:

PDF

Size:

5,000KB

Date:

30 Jun 2016

Maiden Prelims Press Release

Type:

PDF

Size:

604KB

Date:

14 Jun 2016

Admission Document

Type:

PDF

Size:

3,000KB

Date:

12 Jun 2016

Shield Therapeutics Announces Successful Placing to Raise £32.5 Million and Proposed Admission to AIM

Type:

PDF

Size:

445KB

Date:

12 Jun 2016

Warrant Instrument

Type:

PDF

Size:

1,100KB

Date:

12 Jun 2016

Articles of Association

Type:

PDF

Size:

309KB

Date:

12 Jun 2016

Memorandum of Association

Type:

PDF

Date:

12 Jun 2016